Zephex®, Mexichem’s leading brand of HFA medical propellants, will be exhibiting at DDL in Edinburgh from 6th – 9th December, offering insight into its recent developmental work and advice on current issues such as legislative changes.
Mexichem has built on an investment program across the Zephex® business, including substantial increases in package and isotank numbers, with developmental research into new propellants to meet the future requirements of pharmaceutical and environmental regulation.
The Zephex® team (Stand 115) will also be on hand to discuss developments in legislation relevant to the medical propellants industry, including the recent Kigali Amendment to the Montreal Protocol and the EU F-Gas Regulation.